Published Date: 30 Aug 2025
The demographics of lung cancer change every day. The disease, which directly affects the respiratory system, has long been associated with smokers—but that is rapidly changing.
Read Full NewsFrontlines with Frontera, a podcast hosted by neurointensivist Jennifer Frontera, MD, brings you an exclusive interview with Sahar Zafar, MD, MBBS. [LISTEN TIME: 30 minutes]
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending December 19, 2025.
GLP-1 research in neurology is on the rise, with several pivotal studies lending insights into their role.
Fear of Movement, Central Sensitization May Worsen Outcomes in Gout
FDA Extends PDUFA Date for Reproxalap in Dry Eye Disease to March 2026
FDA Accepts, Grants Priority Review to Veligrotug BLA for Thyroid Eye Disease
Weight-Loss Interventions Improve Psoriasis Severity, Quality of Life
1.
Ineffective medication can remove the "worst fear" of schizophrenia.
2.
How access to specialized cancer centers affects glioblastoma outcomes
3.
Data indicate 1 in 3 US adults unaware of connection between HPV and cancers
4.
Since 2000, the outlook for multiple myeloma has improved.
5.
Characterizing metastatic disease during adaptive therapy by using dynamic biomarkers and mathematical modeling.
1.
Multimodal Data Fusion with Deep Neural Networks - Revolutionizing Oncology with Precision Cancer Diagnosis 2025
2.
Organoids & Single-Cell Tools: Breakthroughs in Colorectal Cancer Research
3.
Advancements in Squamous Cell Carcinoma Treatment: Decoding Survival Strategies and Molecular Pathways to Improve Cure Rates
4.
Landmark Medical Oncology Trials Redefining Early Breast Cancer Management
5.
Can We Repurpose BV-CHP for Better Outcomes in Peripheral T-Cell Lymphoma?
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Virtual Case Study on Pedal Edema and Triple Vessel Disease - An Initiative by Hidoc Dr.
2.
Expert Group meeting with the management of EGFR mutation positive NSCLC - Part IV
3.
Navigating the Complexities of Ph Negative ALL - Part XI
4.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part IV
5.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation